Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020)
Nephros (NEPH) recorded quarterly Total Non-Current Liabilities of -$5.3 million in Q4 2020, down 239.94% quarter-over-quarter from $3.8 million in Q3 2020, and down 245.93% on a YoY basis from $3.6 million in Q1 2020.
Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020) Analysis & Trends
Nephros' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at -$5.3 million for Q4 2020.
- In Q4 2020, Total Non-Current Liabilities fell 245.93% year-over-year to -$5.3 million; the TTM figure through Dec 2020 stood at -$5.3 million (down 245.93% YoY), while the FY2020 annual figure was -$5.3 million, down 245.93% from the prior year.
- Total Non-Current Liabilities was -$5.3 million for Q4 2020 at Nephros, down from $3.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $5.0 million in Q2 2019 to a low of -$5.3 million in Q4 2020.
- Historically, Total Non-Current Liabilities has averaged $3.2 million across 3 years, with a median of $4.2 million in 2020.
- The sharpest annual moves came in 2019 and 2020: Total Non-Current Liabilities gained 4.09% in 2019, then sank 245.93% in 2020.
- A 3-year view of Total Non-Current Liabilities shows it stood at $3.5 million in 2018, then gained by 4.09% to $3.6 million in 2019, then tumbled by 245.93% to -$5.3 million in 2020.
- The last three Total Non-Current Liabilities figures came in at -$5.3 million (Q4 2020), $3.8 million (Q3 2020), and $4.2 million (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5.31 Mn |
| Sep 30, 2020 | 3.80 Mn |
| Jun 30, 2020 | 4.19 Mn |
| Mar 31, 2020 | 4.46 Mn |
| Dec 31, 2019 | 3.64 Mn |
| Sep 30, 2019 | 4.75 Mn |
| Jun 30, 2019 | 5.05 Mn |
| Mar 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | 3.50 Mn |
| Sep 30, 2015 | 1.51 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Mar 31, 2015 | 1.66 Mn |
| Dec 31, 2014 | 1.66 Mn |
| Sep 30, 2014 | -3.63 Mn |
| Jun 30, 2014 | -8.41 Mn |
| Mar 31, 2014 | -3.57 Mn |
| Dec 31, 2013 | 3.50 Mn |
| Sep 30, 2013 | -5.65 Mn |
| Jun 30, 2013 | -3.94 Mn |
| Mar 31, 2013 | -939,000.00 |